KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) EPS (Weighted Average and Diluted) (2021 - 2025)

ClearPoint Neuro (CLPT) has disclosed EPS (Weighted Average and Diluted) for 8 consecutive years, with -$0.27 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 35.0% to -$0.27 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.91 through Dec 2025, down 30.0% year-over-year, with the annual reading at -$0.9 for FY2025, 28.57% down from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.27 in Q4 2025 for ClearPoint Neuro, down from -$0.21 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.13 in Q1 2021 to a low of -$0.29 in Q2 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.19 across 5 years, with a median of -$0.18 in 2021.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 61.11% in 2023 and later surged 44.83% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.19 in 2021, then grew by 5.26% to -$0.18 in 2022, then decreased by 5.56% to -$0.19 in 2023, then fell by 5.26% to -$0.2 in 2024, then crashed by 35.0% to -$0.27 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CLPT at -$0.27 in Q4 2025, -$0.21 in Q3 2025, and -$0.21 in Q2 2025.